Cipla (CIPLA) — Corporate Action

📢 Key Event
NCLT approves Cipla's merger with Inzpera Healthsciences

🔄 What Changed
NCLT approval of amalgamation scheme

💡 Investor Takeaway
The merger consolidates Cipla's operations and reduces costs without diluting shareholder value.

Cipla announced that the National Company Law Tribunal approved its scheme to amalgamate its wholly owned subsidiary Inzpera Healthsciences Limited into Cipla, effective April 1, 2026. The merger consolidates operations, reduces overheads, and improves cash management without issuing new shares or affecting creditor rights. Shareholders of Inzpera will see their shares cancelled as part of the absorption.

📄 View Original Announcement (PDF)

📊 Stock Analysis — CIPLA ✨ Ask AI About This

About Cipla Limited (CIPLA)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹1,14,390.9 Cr P/E: 33.9 ROE: 9.8% ROCE: 13.2% Div Yield: 0.92%

View full CIPLA stock details →

📡 Get AI alerts when CIPLA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track CIPLA — Free

💡 Ask AI about this filing

"How will the merger affect Cipla's EPS and margins?" "What is the expected cost savings from the consolidation?" "How will the combined entity's debt profile change?"

Ask AI Free →

📊 More CIPLA filings

See all CIPLA filings →

🔥 Also filed on 19 August 2026

GOCOLORS Go Fashion (India) Limited Annual Report OIL Oil India Limited Corporate Action GLAXO GlaxoSmithKline Pharmaceuticals Limited Financial Results TIL TIL Limited Financial Results SETUINFRA Setubandhan Infrastructure Limited Financial Results ASALCBR Associated Alcohols & Breweries Ltd. Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when CIPLA files new disclosures

Track CIPLA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track CIPLA — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd